Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,351 | 434 | 99.8% |
| Education | $20.25 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,512 | 39 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $862.59 | 39 | $0 (2022) |
| ABBVIE INC. | $776.68 | 52 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $706.40 | 23 | $0 (2021) |
| Novo Nordisk Inc | $612.76 | 48 | $0 (2023) |
| Lilly USA, LLC | $581.60 | 49 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $484.59 | 26 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $290.63 | 28 | $0 (2021) |
| Amarin Pharma Inc. | $253.04 | 16 | $0 (2022) |
| GlaxoSmithKline, LLC. | $228.63 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.32 | 9 | ABBVIE INC. ($74.03) |
| 2023 | $162.91 | 10 | Novo Nordisk Inc ($54.09) |
| 2022 | $770.10 | 48 | ABBVIE INC. ($144.03) |
| 2021 | $1,422 | 99 | AbbVie Inc. ($416.03) |
| 2020 | $1,760 | 99 | Boehringer Ingelheim Pharmaceuticals, Inc. ($179.92) |
| 2019 | $2,933 | 135 | Amgen Inc. ($653.12) |
| 2018 | $1,058 | 34 | Amgen Inc. ($549.96) |
| 2017 | $42.55 | 2 | Novartis Pharmaceuticals Corporation ($24.31) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, AREXVY | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: VACCINES | ||||||
| 09/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ALK-Abello, Inc | Grastek (Drug), Odactra, Ragwitek | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Allergy and Immunology | ||||||
| 07/19/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Hyperkalemia | ||||||
| 07/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Oncology | ||||||
| 06/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes Care | ||||||
| 08/21/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Obesity | ||||||
| 08/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Diabetes | ||||||
| 07/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 06/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Obesity | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Oncology | ||||||
| 05/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: INSOMNIA | ||||||
| 12/23/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Diabetes Care | ||||||
| 11/08/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Inflammation | ||||||
| 09/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Gastroenterology | ||||||
| 07/26/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,265 | 1,854 | $293,526 | $106,975 |
| 2022 | 21 | 985 | 1,741 | $190,915 | $80,598 |
| 2021 | 18 | 1,051 | 2,225 | $182,121 | $52,858 |
| 2020 | 21 | 1,522 | 2,956 | $222,710 | $70,580 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 328 | 542 | $138,720 | $46,495 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 160 | 224 | $81,276 | $28,560 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $29,470 | $14,207 | 48.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 100 | $12,686 | $4,826 | 38.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $8,852 | $3,108 | 35.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,358 | $2,100 | 48.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 106 | 106 | $3,837 | $1,876 | 48.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 74 | 74 | $2,726 | $1,292 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,363 | $862.71 | 36.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 84 | $2,427 | $828.40 | 34.1% |
| 98966 | Telephone medical discussion provided by nonphysician professional, 5-10 minutes | Office | 2023 | 50 | 58 | $1,514 | $575.12 | 38.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 39 | 43 | $835.06 | $399.84 | 47.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 40 | $1,148 | $360.96 | 31.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 18 | $815.40 | $264.90 | 32.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 18 | 19 | $478.80 | $234.65 | 49.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 60 | 87 | $393.00 | $191.40 | 48.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 23 | 32 | $443.50 | $186.29 | 42.0% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 14 | $414.12 | $185.96 | 44.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 31 | $186.00 | $182.28 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 11 | 12 | $321.36 | $157.44 | 49.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 31 | 144 | $187.40 | $53.55 | 28.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 71 | $72.42 | $28.08 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 451 | $84,117 | $37,356 | 44.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 136 | 246 | $66,822 | $27,300 | 40.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $5,210 | $3,698 | 71.0% |
About Dr. Shane Sampson, MD
Dr. Shane Sampson, MD is a Family Medicine healthcare provider based in Centerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023080116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shane Sampson, MD has received a total of $8,371 in payments from pharmaceutical and medical device companies, with $222.32 received in 2024. These payments were reported across 436 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,351).
As a Medicare-enrolled provider, Sampson has provided services to 4,823 Medicare beneficiaries, totaling 8,776 services with total Medicare billing of $311,012. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Centerville, OH
- Active Since 02/03/2006
- Last Updated 03/01/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023080116
Products in Payments
- FARXIGA (Drug) $617.86
- JARDIANCE (Drug) $447.94
- Prolia (Biological) $443.29
- INVOKANA (Drug) $443.16
- EVENITY (Biological) $411.20
- Ozempic (Drug) $356.91
- Repatha (Biological) $326.15
- XARELTO (Drug) $263.24
- Aimovig (Biological) $261.83
- Vascepa (Drug) $253.04
- VRAYLAR (Drug) $214.50
- EMGALITY (Drug) $173.81
- JANUVIA (Drug) $170.10
- UBRELVY (Drug) $144.96
- RINVOQ (Biological) $139.68
- TRADJENTA (Drug) $135.67
- SYMBICORT (Drug) $127.09
- Yupelri (Drug) $125.00
- AJOVY (Drug) $123.53
- NEXLIZET (Drug) $122.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Centerville
Dr. Morris Brown, Md, MD
Family Medicine — Payments: $58,099
Dr. Christopher Sesslar, M.d, M.D
Family Medicine — Payments: $36,984
Jeffrey Gleick, Md, MD
Family Medicine — Payments: $22,015
Mark Jeffries, Do, DO
Family Medicine — Payments: $10,976
Ms. Michelle Russell, Do, DO
Family Medicine — Payments: $5,455
Dr. John Murphy, D.o, D.O
Family Medicine — Payments: $2,724